nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—stomach cancer	0.615	1	CbGaD
Risedronate—Histamine Phosphate—HRH4—stomach cancer	0.00461	0.676	CrCbGaD
Risedronate—FDPS—hematopoietic system—stomach cancer	0.00427	0.0965	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—stomach cancer	0.00376	0.085	CbGeAlD
Risedronate—FDPS—pancreas—stomach cancer	0.00347	0.0786	CbGeAlD
Risedronate—PTGS2—blood vessel—stomach cancer	0.00307	0.0695	CbGeAlD
Risedronate—FDPS—lymphoid tissue—stomach cancer	0.003	0.068	CbGeAlD
Risedronate—FDPS—digestive system—stomach cancer	0.00297	0.0671	CbGeAlD
Risedronate—PTGS2—gall bladder—stomach cancer	0.00289	0.0654	CbGeAlD
Risedronate—FDPS—bone marrow—stomach cancer	0.00273	0.0619	CbGeAlD
Risedronate—FDPS—endocrine gland—stomach cancer	0.00245	0.0555	CbGeAlD
Risedronate—FDPS—liver—stomach cancer	0.00221	0.05	CbGeAlD
Risedronate—Zoledronate—CA2—stomach cancer	0.00221	0.324	CrCbGaD
Risedronate—FDPS—lymph node—stomach cancer	0.00169	0.0383	CbGeAlD
Risedronate—PTGS2—hematopoietic system—stomach cancer	0.00164	0.037	CbGeAlD
Risedronate—PTGS2—epithelium—stomach cancer	0.00149	0.0338	CbGeAlD
Risedronate—PTGS2—smooth muscle tissue—stomach cancer	0.00144	0.0326	CbGeAlD
Risedronate—PTGS2—pancreas—stomach cancer	0.00133	0.0301	CbGeAlD
Risedronate—PTGS2—lymphoid tissue—stomach cancer	0.00115	0.026	CbGeAlD
Risedronate—PTGS2—digestive system—stomach cancer	0.00114	0.0257	CbGeAlD
Risedronate—PTGS2—bone marrow—stomach cancer	0.00105	0.0237	CbGeAlD
Risedronate—PTGS2—endocrine gland—stomach cancer	0.00094	0.0213	CbGeAlD
Risedronate—PTGS2—liver—stomach cancer	0.000847	0.0192	CbGeAlD
Risedronate—PTGS2—lymph node—stomach cancer	0.000649	0.0147	CbGeAlD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—stomach cancer	0.000374	0.00548	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NDUFV1—stomach cancer	0.000373	0.00546	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NDUFS1—stomach cancer	0.000373	0.00546	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000364	0.00534	CbGpPWpGaD
Risedronate—FDPS—Metabolism—BLVRB—stomach cancer	0.000332	0.00487	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PGLS—stomach cancer	0.000332	0.00487	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—VEGFA—stomach cancer	0.000326	0.00477	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HSPA8—stomach cancer	0.000318	0.00465	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPAP2A—stomach cancer	0.000317	0.00464	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—MAPK3—stomach cancer	0.000308	0.00451	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000305	0.00446	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—LGALS3—stomach cancer	0.000305	0.00446	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—MAPK1—stomach cancer	0.000293	0.0043	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NDUFA2—stomach cancer	0.000282	0.00414	CbGpPWpGaD
Risedronate—FDPS—Metabolism—FBP1—stomach cancer	0.000282	0.00414	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CA1—stomach cancer	0.000282	0.00414	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CKB—stomach cancer	0.000282	0.00414	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—stomach cancer	0.000279	0.00409	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	0.000267	0.00391	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—stomach cancer	0.000267	0.00391	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—stomach cancer	0.000266	0.00389	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PLIN2—stomach cancer	0.000266	0.00389	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CA2—stomach cancer	0.000258	0.00378	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NT5E—stomach cancer	0.000252	0.00369	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PGAM1—stomach cancer	0.000252	0.00369	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000246	0.0036	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000246	0.0036	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ANXA1—stomach cancer	0.000246	0.0036	CbGpPWpGaD
Risedronate—Hypersensitivity—Fluorouracil—stomach cancer	0.000243	0.000915	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—stomach cancer	0.000242	0.00355	CbGpPWpGaD
Risedronate—Dry mouth—Docetaxel—stomach cancer	0.000242	0.000914	CcSEcCtD
Risedronate—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000242	0.000914	CcSEcCtD
Risedronate—Haemoglobin—Methotrexate—stomach cancer	0.000242	0.000914	CcSEcCtD
Risedronate—Haemorrhage—Methotrexate—stomach cancer	0.000241	0.000909	CcSEcCtD
Risedronate—FDPS—Metabolism—PLCE1—stomach cancer	0.00024	0.00352	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALDH7A1—stomach cancer	0.00024	0.00352	CbGpPWpGaD
Risedronate—Chest pain—Capecitabine—stomach cancer	0.00024	0.000905	CcSEcCtD
Risedronate—Myalgia—Capecitabine—stomach cancer	0.00024	0.000905	CcSEcCtD
Risedronate—Arthralgia—Capecitabine—stomach cancer	0.00024	0.000905	CcSEcCtD
Risedronate—Pharyngitis—Methotrexate—stomach cancer	0.000239	0.000902	CcSEcCtD
Risedronate—Anxiety—Capecitabine—stomach cancer	0.000239	0.000902	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000238	0.000899	CcSEcCtD
Risedronate—Urinary tract disorder—Methotrexate—stomach cancer	0.000238	0.000898	CcSEcCtD
Risedronate—Hepatobiliary disease—Epirubicin—stomach cancer	0.000238	0.000896	CcSEcCtD
Risedronate—Urethral disorder—Methotrexate—stomach cancer	0.000236	0.000891	CcSEcCtD
Risedronate—Infection—Docetaxel—stomach cancer	0.000236	0.00089	CcSEcCtD
Risedronate—Sinusitis—Epirubicin—stomach cancer	0.000236	0.000889	CcSEcCtD
Risedronate—Diarrhoea—Irinotecan—stomach cancer	0.000235	0.000887	CcSEcCtD
Risedronate—Dry mouth—Capecitabine—stomach cancer	0.000235	0.000885	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—stomach cancer	0.000234	0.000882	CcSEcCtD
Risedronate—Shock—Docetaxel—stomach cancer	0.000234	0.000881	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—GADD45A—stomach cancer	0.000234	0.00342	CbGpPWpGaD
Risedronate—Nervous system disorder—Docetaxel—stomach cancer	0.000233	0.000879	CcSEcCtD
Risedronate—Pruritus—Fluorouracil—stomach cancer	0.000233	0.000878	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—stomach cancer	0.000232	0.000877	CcSEcCtD
Risedronate—Infestation—Doxorubicin—stomach cancer	0.000232	0.000877	CcSEcCtD
Risedronate—Skin disorder—Docetaxel—stomach cancer	0.000231	0.00087	CcSEcCtD
Risedronate—FDPS—Metabolism—UMPS—stomach cancer	0.00023	0.00337	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—stomach cancer	0.000229	0.00335	CbGpPWpGaD
Risedronate—Infection—Capecitabine—stomach cancer	0.000229	0.000862	CcSEcCtD
Risedronate—Dizziness—Irinotecan—stomach cancer	0.000227	0.000857	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—stomach cancer	0.000227	0.000855	CcSEcCtD
Risedronate—Shock—Capecitabine—stomach cancer	0.000226	0.000853	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—stomach cancer	0.000226	0.000853	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—stomach cancer	0.000226	0.000852	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—stomach cancer	0.000226	0.000852	CcSEcCtD
Risedronate—Nervous system disorder—Capecitabine—stomach cancer	0.000226	0.000851	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—stomach cancer	0.000226	0.000851	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—stomach cancer	0.000225	0.0033	CbGpPWpGaD
Risedronate—Eye disorder—Methotrexate—stomach cancer	0.000225	0.000849	CcSEcCtD
Risedronate—Diarrhoea—Fluorouracil—stomach cancer	0.000225	0.000849	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—stomach cancer	0.000225	0.000847	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—stomach cancer	0.000224	0.000844	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—stomach cancer	0.000224	0.000844	CcSEcCtD
Risedronate—Skin disorder—Capecitabine—stomach cancer	0.000223	0.000843	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—GSTM1—stomach cancer	0.000223	0.00327	CbGpPWpGaD
Risedronate—Urinary tract disorder—Epirubicin—stomach cancer	0.000223	0.00084	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—stomach cancer	0.000222	0.000838	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—stomach cancer	0.000222	0.000836	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—stomach cancer	0.000221	0.000834	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00022	0.000829	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—stomach cancer	0.000219	0.000825	CcSEcCtD
Risedronate—Vomiting—Irinotecan—stomach cancer	0.000219	0.000824	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—stomach cancer	0.000218	0.000823	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—stomach cancer	0.000218	0.000821	CcSEcCtD
Risedronate—Dizziness—Fluorouracil—stomach cancer	0.000218	0.000821	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—stomach cancer	0.000217	0.000819	CcSEcCtD
Risedronate—Rash—Irinotecan—stomach cancer	0.000217	0.000817	CcSEcCtD
Risedronate—Dermatitis—Irinotecan—stomach cancer	0.000216	0.000816	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000216	0.000816	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—SOD2—stomach cancer	0.000216	0.00316	CbGpPWpGaD
Risedronate—Headache—Irinotecan—stomach cancer	0.000215	0.000812	CcSEcCtD
Risedronate—Insomnia—Docetaxel—stomach cancer	0.000215	0.00081	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000214	0.00314	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PDHA1—stomach cancer	0.000214	0.00314	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ECHS1—stomach cancer	0.000214	0.00314	CbGpPWpGaD
Risedronate—Paraesthesia—Docetaxel—stomach cancer	0.000213	0.000805	CcSEcCtD
Risedronate—Dyspnoea—Docetaxel—stomach cancer	0.000212	0.000799	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—stomach cancer	0.000211	0.000796	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—stomach cancer	0.000211	0.000795	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—stomach cancer	0.00021	0.000793	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—stomach cancer	0.00021	0.000791	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—stomach cancer	0.00021	0.000791	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00021	0.00079	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—stomach cancer	0.000209	0.000789	CcSEcCtD
Risedronate—Vomiting—Fluorouracil—stomach cancer	0.000209	0.000789	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—stomach cancer	0.000209	0.000789	CcSEcCtD
Risedronate—Dyspepsia—Docetaxel—stomach cancer	0.000209	0.000789	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—stomach cancer	0.000209	0.000787	CcSEcCtD
Risedronate—Insomnia—Capecitabine—stomach cancer	0.000208	0.000785	CcSEcCtD
Risedronate—Rash—Fluorouracil—stomach cancer	0.000208	0.000783	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—APEX1—stomach cancer	0.000207	0.00304	CbGpPWpGaD
Risedronate—Dermatitis—Fluorouracil—stomach cancer	0.000207	0.000782	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—stomach cancer	0.000207	0.000781	CcSEcCtD
Risedronate—Paraesthesia—Capecitabine—stomach cancer	0.000207	0.000779	CcSEcCtD
Risedronate—Headache—Fluorouracil—stomach cancer	0.000206	0.000778	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—stomach cancer	0.000206	0.000777	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—stomach cancer	0.000206	0.000775	CcSEcCtD
Risedronate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000205	0.000774	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—stomach cancer	0.000205	0.000773	CcSEcCtD
Risedronate—Dyspnoea—Capecitabine—stomach cancer	0.000205	0.000773	CcSEcCtD
Risedronate—Fatigue—Docetaxel—stomach cancer	0.000205	0.000772	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—stomach cancer	0.000205	0.000772	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—stomach cancer	0.000205	0.000772	CcSEcCtD
Risedronate—Nausea—Irinotecan—stomach cancer	0.000204	0.00077	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—stomach cancer	0.000204	0.000768	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—stomach cancer	0.000203	0.000767	CcSEcCtD
Risedronate—Pain—Docetaxel—stomach cancer	0.000203	0.000766	CcSEcCtD
Risedronate—Constipation—Docetaxel—stomach cancer	0.000203	0.000766	CcSEcCtD
Risedronate—Back pain—Methotrexate—stomach cancer	0.000203	0.000765	CcSEcCtD
Risedronate—Dyspepsia—Capecitabine—stomach cancer	0.000202	0.000764	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—stomach cancer	0.000201	0.00076	CcSEcCtD
Risedronate—FDPS—Metabolism—FADS1—stomach cancer	0.000201	0.00295	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TYMP—stomach cancer	0.000201	0.00295	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000199	0.000749	CcSEcCtD
Risedronate—Fatigue—Capecitabine—stomach cancer	0.000198	0.000748	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—stomach cancer	0.000198	0.000745	CcSEcCtD
Risedronate—Constipation—Capecitabine—stomach cancer	0.000197	0.000742	CcSEcCtD
Risedronate—Pain—Capecitabine—stomach cancer	0.000197	0.000742	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—stomach cancer	0.000196	0.00074	CcSEcCtD
Risedronate—Nausea—Fluorouracil—stomach cancer	0.000196	0.000737	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—stomach cancer	0.000195	0.000736	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—stomach cancer	0.000195	0.000734	CcSEcCtD
Risedronate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000194	0.000733	CcSEcCtD
Risedronate—Anaemia—Methotrexate—stomach cancer	0.000194	0.000731	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—stomach cancer	0.000194	0.00073	CcSEcCtD
Risedronate—Flatulence—Epirubicin—stomach cancer	0.000193	0.00073	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000193	0.00283	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—stomach cancer	0.000192	0.00281	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—MTHFR—stomach cancer	0.00019	0.00279	CbGpPWpGaD
Risedronate—Back pain—Epirubicin—stomach cancer	0.00019	0.000716	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—stomach cancer	0.000189	0.000714	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—stomach cancer	0.000189	0.000712	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—stomach cancer	0.000188	0.000711	CcSEcCtD
Risedronate—Vertigo—Methotrexate—stomach cancer	0.000188	0.000711	CcSEcCtD
Risedronate—FDPS—Metabolism—SREBF2—stomach cancer	0.000188	0.00276	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000188	0.000709	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—stomach cancer	0.000188	0.000709	CcSEcCtD
Risedronate—Body temperature increased—Docetaxel—stomach cancer	0.000188	0.000708	CcSEcCtD
Risedronate—Abdominal pain—Docetaxel—stomach cancer	0.000188	0.000708	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—stomach cancer	0.000186	0.000703	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000186	0.00273	CbGpPWpGaD
Risedronate—FDPS—Metabolism—RORA—stomach cancer	0.000186	0.00273	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—stomach cancer	0.000185	0.00271	CbGpPWpGaD
Risedronate—Cough—Methotrexate—stomach cancer	0.000183	0.00069	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—stomach cancer	0.000183	0.00069	CcSEcCtD
Risedronate—Urticaria—Capecitabine—stomach cancer	0.000183	0.000689	CcSEcCtD
Risedronate—Body temperature increased—Capecitabine—stomach cancer	0.000182	0.000686	CcSEcCtD
Risedronate—Abdominal pain—Capecitabine—stomach cancer	0.000182	0.000686	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—stomach cancer	0.000182	0.000685	CcSEcCtD
Risedronate—Anaemia—Epirubicin—stomach cancer	0.000181	0.000684	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—stomach cancer	0.000179	0.000675	CcSEcCtD
Risedronate—Myalgia—Methotrexate—stomach cancer	0.000179	0.000674	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—stomach cancer	0.000179	0.000674	CcSEcCtD
Risedronate—Chest pain—Methotrexate—stomach cancer	0.000179	0.000674	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—BDNF—stomach cancer	0.000178	0.00261	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000178	0.00261	CbGpPWpGaD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000177	0.000669	CcSEcCtD
Risedronate—Vertigo—Epirubicin—stomach cancer	0.000176	0.000665	CcSEcCtD
Risedronate—Syncope—Epirubicin—stomach cancer	0.000176	0.000664	CcSEcCtD
Risedronate—Back pain—Doxorubicin—stomach cancer	0.000176	0.000663	CcSEcCtD
Risedronate—Hypersensitivity—Docetaxel—stomach cancer	0.000175	0.00066	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—APOA1—stomach cancer	0.000175	0.00256	CbGpPWpGaD
Risedronate—Muscle spasms—Doxorubicin—stomach cancer	0.000175	0.000659	CcSEcCtD
Risedronate—FDPS—Metabolism—ALDOB—stomach cancer	0.000174	0.00256	CbGpPWpGaD
Risedronate—Loss of consciousness—Epirubicin—stomach cancer	0.000173	0.000651	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—stomach cancer	0.000172	0.00252	CbGpPWpGaD
Risedronate—Cough—Epirubicin—stomach cancer	0.000171	0.000646	CcSEcCtD
Risedronate—Asthenia—Docetaxel—stomach cancer	0.00017	0.000643	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.00017	0.0025	CbGpPWpGaD
Risedronate—Infection—Methotrexate—stomach cancer	0.00017	0.000642	CcSEcCtD
Risedronate—Hypertension—Epirubicin—stomach cancer	0.00017	0.000639	CcSEcCtD
Risedronate—Hypersensitivity—Capecitabine—stomach cancer	0.000169	0.000639	CcSEcCtD
Risedronate—Pruritus—Docetaxel—stomach cancer	0.000168	0.000634	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—stomach cancer	0.000168	0.000633	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—stomach cancer	0.000168	0.000633	CcSEcCtD
Risedronate—Myalgia—Epirubicin—stomach cancer	0.000167	0.00063	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—stomach cancer	0.000167	0.00063	CcSEcCtD
Risedronate—Chest pain—Epirubicin—stomach cancer	0.000167	0.00063	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000167	0.00245	CbGpPWpGaD
Risedronate—Anxiety—Epirubicin—stomach cancer	0.000167	0.000628	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—stomach cancer	0.000166	0.000627	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000166	0.000626	CcSEcCtD
Risedronate—Asthenia—Capecitabine—stomach cancer	0.000165	0.000622	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000165	0.00241	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000164	0.0024	CbGpPWpGaD
Risedronate—Dry mouth—Epirubicin—stomach cancer	0.000163	0.000617	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—stomach cancer	0.000163	0.000616	CcSEcCtD
Risedronate—Syncope—Doxorubicin—stomach cancer	0.000163	0.000614	CcSEcCtD
Risedronate—Pruritus—Capecitabine—stomach cancer	0.000163	0.000614	CcSEcCtD
Risedronate—Diarrhoea—Docetaxel—stomach cancer	0.000163	0.000613	CcSEcCtD
Risedronate—FDPS—Metabolism—ALOX5—stomach cancer	0.000162	0.00238	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.000161	0.00235	CbGpPWpGaD
Risedronate—Loss of consciousness—Doxorubicin—stomach cancer	0.00016	0.000602	CcSEcCtD
Risedronate—FDPS—Metabolism—DPYD—stomach cancer	0.00016	0.00234	CbGpPWpGaD
Risedronate—Infection—Epirubicin—stomach cancer	0.000159	0.0006	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000159	0.00233	CbGpPWpGaD
Risedronate—Cough—Doxorubicin—stomach cancer	0.000159	0.000598	CcSEcCtD
Risedronate—Shock—Epirubicin—stomach cancer	0.000158	0.000595	CcSEcCtD
Risedronate—Diarrhoea—Capecitabine—stomach cancer	0.000157	0.000594	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—stomach cancer	0.000157	0.000593	CcSEcCtD
Risedronate—Dizziness—Docetaxel—stomach cancer	0.000157	0.000592	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—stomach cancer	0.000157	0.000592	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000156	0.000588	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—stomach cancer	0.000156	0.000587	CcSEcCtD
Risedronate—Insomnia—Methotrexate—stomach cancer	0.000155	0.000584	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—stomach cancer	0.000155	0.000583	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—stomach cancer	0.000155	0.000583	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—stomach cancer	0.000155	0.000583	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—stomach cancer	0.000154	0.000581	CcSEcCtD
Risedronate—Paraesthesia—Methotrexate—stomach cancer	0.000154	0.00058	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000154	0.000579	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—stomach cancer	0.000153	0.000576	CcSEcCtD
Risedronate—Dizziness—Capecitabine—stomach cancer	0.000152	0.000574	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—stomach cancer	0.000151	0.00057	CcSEcCtD
Risedronate—Vomiting—Docetaxel—stomach cancer	0.000151	0.00057	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—stomach cancer	0.000151	0.00221	CbGpPWpGaD
Risedronate—Dyspepsia—Methotrexate—stomach cancer	0.000151	0.000568	CcSEcCtD
Risedronate—Rash—Docetaxel—stomach cancer	0.00015	0.000565	CcSEcCtD
Risedronate—Dermatitis—Docetaxel—stomach cancer	0.00015	0.000564	CcSEcCtD
Risedronate—Headache—Docetaxel—stomach cancer	0.000149	0.000561	CcSEcCtD
Risedronate—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000148	0.000558	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000148	0.00216	CbGpPWpGaD
Risedronate—Fatigue—Methotrexate—stomach cancer	0.000148	0.000557	CcSEcCtD
Risedronate—Infection—Doxorubicin—stomach cancer	0.000147	0.000556	CcSEcCtD
Risedronate—Pain—Methotrexate—stomach cancer	0.000146	0.000552	CcSEcCtD
Risedronate—Vomiting—Capecitabine—stomach cancer	0.000146	0.000552	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000146	0.000551	CcSEcCtD
Risedronate—Shock—Doxorubicin—stomach cancer	0.000146	0.00055	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—stomach cancer	0.000145	0.000548	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000145	0.00213	CbGpPWpGaD
Risedronate—Rash—Capecitabine—stomach cancer	0.000145	0.000547	CcSEcCtD
Risedronate—Insomnia—Epirubicin—stomach cancer	0.000145	0.000547	CcSEcCtD
Risedronate—Dermatitis—Capecitabine—stomach cancer	0.000145	0.000546	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000145	0.00212	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000145	0.00212	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000144	0.00212	CbGpPWpGaD
Risedronate—Headache—Capecitabine—stomach cancer	0.000144	0.000543	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—stomach cancer	0.000144	0.000543	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—stomach cancer	0.000144	0.000543	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—stomach cancer	0.000143	0.000539	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000143	0.00209	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTT1—stomach cancer	0.000141	0.00207	CbGpPWpGaD
Risedronate—Nausea—Docetaxel—stomach cancer	0.000141	0.000532	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—stomach cancer	0.000141	0.000532	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—stomach cancer	0.00014	0.000528	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP2A6—stomach cancer	0.000139	0.00204	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000139	0.00204	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—stomach cancer	0.000139	0.00203	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000138	0.000522	CcSEcCtD
Risedronate—Fatigue—Epirubicin—stomach cancer	0.000138	0.000521	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000138	0.00202	CbGpPWpGaD
Risedronate—Constipation—Epirubicin—stomach cancer	0.000137	0.000517	CcSEcCtD
Risedronate—Pain—Epirubicin—stomach cancer	0.000137	0.000517	CcSEcCtD
Risedronate—Nausea—Capecitabine—stomach cancer	0.000137	0.000515	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000137	0.002	CbGpPWpGaD
Risedronate—Urticaria—Methotrexate—stomach cancer	0.000136	0.000513	CcSEcCtD
Risedronate—FDPS—Metabolism—AKR1C3—stomach cancer	0.000136	0.00199	CbGpPWpGaD
Risedronate—Body temperature increased—Methotrexate—stomach cancer	0.000135	0.00051	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—stomach cancer	0.000135	0.00051	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000135	0.000509	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN2A—stomach cancer	0.000135	0.00197	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDK4—stomach cancer	0.000134	0.00197	CbGpPWpGaD
Risedronate—Insomnia—Doxorubicin—stomach cancer	0.000134	0.000506	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—stomach cancer	0.000133	0.000502	CcSEcCtD
Risedronate—FDPS—Metabolism—ENO1—stomach cancer	0.000132	0.00194	CbGpPWpGaD
Risedronate—Dyspnoea—Doxorubicin—stomach cancer	0.000132	0.000499	CcSEcCtD
Risedronate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000131	0.000494	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—stomach cancer	0.000131	0.000492	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.00013	0.00191	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—stomach cancer	0.000129	0.00189	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000128	0.000483	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—stomach cancer	0.000128	0.000482	CcSEcCtD
Risedronate—Urticaria—Epirubicin—stomach cancer	0.000127	0.00048	CcSEcCtD
Risedronate—Pain—Doxorubicin—stomach cancer	0.000127	0.000478	CcSEcCtD
Risedronate—Constipation—Doxorubicin—stomach cancer	0.000127	0.000478	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—stomach cancer	0.000127	0.000478	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—stomach cancer	0.000127	0.000478	CcSEcCtD
Risedronate—Hypersensitivity—Methotrexate—stomach cancer	0.000126	0.000476	CcSEcCtD
Risedronate—Asthenia—Methotrexate—stomach cancer	0.000123	0.000463	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000121	0.00178	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000121	0.000457	CcSEcCtD
Risedronate—Pruritus—Methotrexate—stomach cancer	0.000121	0.000457	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN1B—stomach cancer	0.000119	0.00175	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000119	0.00175	CbGpPWpGaD
Risedronate—Hypersensitivity—Epirubicin—stomach cancer	0.000118	0.000445	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—stomach cancer	0.000118	0.000444	CcSEcCtD
Risedronate—PTGS2—Metabolism—ACAD8—stomach cancer	0.000118	0.00173	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CD44—stomach cancer	0.000117	0.00172	CbGpPWpGaD
Risedronate—Body temperature increased—Doxorubicin—stomach cancer	0.000117	0.000442	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—stomach cancer	0.000117	0.000442	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—stomach cancer	0.000117	0.000442	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000117	0.00172	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000116	0.0017	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000115	0.00169	CbGpPWpGaD
Risedronate—Asthenia—Epirubicin—stomach cancer	0.000115	0.000434	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000114	0.00167	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CCND1—stomach cancer	0.000114	0.00167	CbGpPWpGaD
Risedronate—Pruritus—Epirubicin—stomach cancer	0.000113	0.000428	CcSEcCtD
Risedronate—Dizziness—Methotrexate—stomach cancer	0.000113	0.000427	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—stomach cancer	0.000113	0.00165	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN1A—stomach cancer	0.00011	0.00161	CbGpPWpGaD
Risedronate—Diarrhoea—Epirubicin—stomach cancer	0.00011	0.000413	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—stomach cancer	0.000109	0.000412	CcSEcCtD
Risedronate—Vomiting—Methotrexate—stomach cancer	0.000109	0.000411	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000108	0.00159	CbGpPWpGaD
Risedronate—Rash—Methotrexate—stomach cancer	0.000108	0.000407	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—stomach cancer	0.000108	0.000407	CcSEcCtD
Risedronate—Headache—Methotrexate—stomach cancer	0.000107	0.000405	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—stomach cancer	0.000106	0.000401	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—RHOA—stomach cancer	0.000106	0.00155	CbGpPWpGaD
Risedronate—Dizziness—Epirubicin—stomach cancer	0.000106	0.0004	CcSEcCtD
Risedronate—PTGS2—Metabolism—GMPR2—stomach cancer	0.000105	0.00154	CbGpPWpGaD
Risedronate—Pruritus—Doxorubicin—stomach cancer	0.000105	0.000396	CcSEcCtD
Risedronate—Vomiting—Epirubicin—stomach cancer	0.000102	0.000384	CcSEcCtD
Risedronate—Nausea—Methotrexate—stomach cancer	0.000102	0.000384	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—stomach cancer	0.000101	0.000383	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000101	0.00148	CbGpPWpGaD
Risedronate—Rash—Epirubicin—stomach cancer	0.000101	0.000381	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—stomach cancer	0.000101	0.000381	CcSEcCtD
Risedronate—Headache—Epirubicin—stomach cancer	0.0001	0.000379	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.0001	0.00147	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPP2R1A—stomach cancer	9.97e-05	0.00146	CbGpPWpGaD
Risedronate—Dizziness—Doxorubicin—stomach cancer	9.8e-05	0.00037	CcSEcCtD
Risedronate—FDPS—Metabolism—GSTP1—stomach cancer	9.78e-05	0.00143	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMOX1—stomach cancer	9.65e-05	0.00141	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SUCLG1—stomach cancer	9.6e-05	0.00141	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—IDH3B—stomach cancer	9.6e-05	0.00141	CbGpPWpGaD
Risedronate—Nausea—Epirubicin—stomach cancer	9.52e-05	0.000359	CcSEcCtD
Risedronate—PTGS2—Disease—PGLS—stomach cancer	9.5e-05	0.00139	CbGpPWpGaD
Risedronate—Vomiting—Doxorubicin—stomach cancer	9.43e-05	0.000356	CcSEcCtD
Risedronate—Rash—Doxorubicin—stomach cancer	9.35e-05	0.000353	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—stomach cancer	9.34e-05	0.000352	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CXCL8—stomach cancer	9.3e-05	0.00136	CbGpPWpGaD
Risedronate—Headache—Doxorubicin—stomach cancer	9.29e-05	0.00035	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	9.13e-05	0.00134	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—MYC—stomach cancer	9.13e-05	0.00134	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TYMS—stomach cancer	9.09e-05	0.00133	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	9.09e-05	0.00133	CbGpPWpGaD
Risedronate—PTGS2—Disease—RBP1—stomach cancer	9.06e-05	0.00133	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTM1—stomach cancer	8.99e-05	0.00132	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	8.93e-05	0.00131	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NDUFS1—stomach cancer	8.93e-05	0.00131	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NDUFV1—stomach cancer	8.93e-05	0.00131	CbGpPWpGaD
Risedronate—Nausea—Doxorubicin—stomach cancer	8.81e-05	0.000332	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	8.72e-05	0.00128	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	8.67e-05	0.00127	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	8.6e-05	0.00126	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ERCC2—stomach cancer	8.45e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	8.43e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	8.42e-05	0.00123	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	8.19e-05	0.0012	CbGpPWpGaD
Risedronate—PTGS2—Disease—FBP1—stomach cancer	8.08e-05	0.00118	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	8.01e-05	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PGLS—stomach cancer	7.96e-05	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BLVRB—stomach cancer	7.96e-05	0.00117	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTHFR—stomach cancer	7.94e-05	0.00116	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPAP2A—stomach cancer	7.59e-05	0.00111	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CAV1—stomach cancer	7.33e-05	0.00107	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOA1—stomach cancer	7.31e-05	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.3e-05	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Disease—PGAM1—stomach cancer	7.2e-05	0.00105	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	7.17e-05	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	7.15e-05	0.00105	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7e-05	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MYC—stomach cancer	6.95e-05	0.00102	CbGpPWpGaD
Risedronate—PTGS2—Disease—WIF1—stomach cancer	6.87e-05	0.00101	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	6.8e-05	0.000997	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	6.8e-05	0.000996	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CKB—stomach cancer	6.76e-05	0.000991	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CA1—stomach cancer	6.76e-05	0.000991	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FBP1—stomach cancer	6.76e-05	0.000991	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NDUFA2—stomach cancer	6.76e-05	0.000991	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.67e-05	0.000978	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	6.61e-05	0.000968	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—stomach cancer	6.48e-05	0.000949	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPL13—stomach cancer	6.46e-05	0.000946	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPL18—stomach cancer	6.46e-05	0.000946	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—stomach cancer	6.44e-05	0.000944	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLIN2—stomach cancer	6.36e-05	0.000932	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CA2—stomach cancer	6.19e-05	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	6.18e-05	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Disease—RNF43—stomach cancer	6.12e-05	0.000897	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NT5E—stomach cancer	6.03e-05	0.000883	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PGAM1—stomach cancer	6.03e-05	0.000883	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS15—stomach cancer	6.02e-05	0.000882	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS21—stomach cancer	6.02e-05	0.000882	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.9e-05	0.000864	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.88e-05	0.000862	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—stomach cancer	5.79e-05	0.000849	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLCE1—stomach cancer	5.75e-05	0.000843	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDH7A1—stomach cancer	5.75e-05	0.000843	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TP53—stomach cancer	5.71e-05	0.000837	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.7e-05	0.000836	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.57e-05	0.000816	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NOS3—stomach cancer	5.54e-05	0.000812	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UMPS—stomach cancer	5.51e-05	0.000808	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—stomach cancer	5.23e-05	0.000766	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	5.14e-05	0.000753	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PDHA1—stomach cancer	5.13e-05	0.000751	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ECHS1—stomach cancer	5.13e-05	0.000751	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—stomach cancer	5.07e-05	0.000742	CbGpPWpGaD
Risedronate—PTGS2—Disease—ALDOB—stomach cancer	4.99e-05	0.000731	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPL15—stomach cancer	4.89e-05	0.000717	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.86e-05	0.000712	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FADS1—stomach cancer	4.82e-05	0.000706	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TYMP—stomach cancer	4.82e-05	0.000706	CbGpPWpGaD
Risedronate—PTGS2—Disease—NPM1—stomach cancer	4.8e-05	0.000704	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.73e-05	0.000693	CbGpPWpGaD
Risedronate—PTGS2—Disease—RBP4—stomach cancer	4.64e-05	0.00068	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.63e-05	0.000678	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.63e-05	0.000678	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS26—stomach cancer	4.56e-05	0.000669	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPIA—stomach cancer	4.53e-05	0.000663	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SREBF2—stomach cancer	4.51e-05	0.000661	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—RORA—stomach cancer	4.46e-05	0.000653	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.41e-05	0.000645	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.37e-05	0.00064	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDOB—stomach cancer	4.18e-05	0.000612	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.02e-05	0.000588	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.94e-05	0.000577	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.93e-05	0.000576	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALOX5—stomach cancer	3.89e-05	0.000569	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.88e-05	0.000569	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS19—stomach cancer	3.88e-05	0.000569	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKR1C3—stomach cancer	3.88e-05	0.000569	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DPYD—stomach cancer	3.82e-05	0.00056	CbGpPWpGaD
Risedronate—PTGS2—Disease—ENO1—stomach cancer	3.78e-05	0.000554	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.46e-05	0.000508	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS6—stomach cancer	3.43e-05	0.000503	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTT1—stomach cancer	3.38e-05	0.000495	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD44—stomach cancer	3.35e-05	0.000491	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2A6—stomach cancer	3.34e-05	0.000489	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKR1C3—stomach cancer	3.25e-05	0.000476	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ENO1—stomach cancer	3.17e-05	0.000464	CbGpPWpGaD
Risedronate—PTGS2—Disease—HBEGF—stomach cancer	3.15e-05	0.000462	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CA—stomach cancer	3.12e-05	0.000457	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.12e-05	0.000456	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP2R1A—stomach cancer	2.85e-05	0.000418	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CD44—stomach cancer	2.81e-05	0.000412	CbGpPWpGaD
Risedronate—PTGS2—Disease—SMAD4—stomach cancer	2.65e-05	0.000388	CbGpPWpGaD
Risedronate—PTGS2—Disease—FYN—stomach cancer	2.51e-05	0.000368	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERCC2—stomach cancer	2.42e-05	0.000354	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPP2R1A—stomach cancer	2.39e-05	0.00035	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGFR2—stomach cancer	2.36e-05	0.000346	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTP1—stomach cancer	2.34e-05	0.000343	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—stomach cancer	2.31e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—stomach cancer	2.27e-05	0.000333	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TYMS—stomach cancer	2.18e-05	0.000319	CbGpPWpGaD
Risedronate—PTGS2—Disease—IRS2—stomach cancer	2.16e-05	0.000317	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—stomach cancer	2.15e-05	0.000315	CbGpPWpGaD
Risedronate—PTGS2—Disease—CAV1—stomach cancer	2.1e-05	0.000307	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOA1—stomach cancer	2.09e-05	0.000306	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ERCC2—stomach cancer	2.02e-05	0.000297	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6ST—stomach cancer	1.99e-05	0.000291	CbGpPWpGaD
Risedronate—PTGS2—Disease—APC—stomach cancer	1.91e-05	0.00028	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—stomach cancer	1.9e-05	0.000279	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6R—stomach cancer	1.77e-05	0.00026	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAV1—stomach cancer	1.76e-05	0.000257	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA1—stomach cancer	1.75e-05	0.000257	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.68e-05	0.000246	CbGpPWpGaD
Risedronate—PTGS2—Disease—SERPINE1—stomach cancer	1.66e-05	0.000243	CbGpPWpGaD
Risedronate—PTGS2—Disease—RHOA—stomach cancer	1.6e-05	0.000235	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS3—stomach cancer	1.58e-05	0.000232	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—stomach cancer	1.54e-05	0.000226	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB2—stomach cancer	1.48e-05	0.000217	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—stomach cancer	1.39e-05	0.000203	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1B—stomach cancer	1.37e-05	0.000201	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NOS3—stomach cancer	1.33e-05	0.000194	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1A—stomach cancer	1.27e-05	0.000186	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—stomach cancer	1.13e-05	0.000166	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK3—stomach cancer	1.08e-05	0.000158	CbGpPWpGaD
Risedronate—PTGS2—Disease—MYC—stomach cancer	1.05e-05	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK1—stomach cancer	1.03e-05	0.000151	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGFR—stomach cancer	1.03e-05	0.000151	CbGpPWpGaD
Risedronate—PTGS2—Disease—KRAS—stomach cancer	9.71e-06	0.000142	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CA—stomach cancer	8.92e-06	0.000131	CbGpPWpGaD
Risedronate—PTGS2—Disease—HRAS—stomach cancer	8.25e-06	0.000121	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—stomach cancer	7.9e-06	0.000116	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CA—stomach cancer	7.47e-06	0.000109	CbGpPWpGaD
